Relationship Status between Vancomycin Loading Dose and Treatment Failure in Patients with MRSA Bacteremia: It’s Complicated

[1]  S. C. Forland,et al.  Outcomes of Vancomycin plus a β-Lactam versus Vancomycin Only for Treatment of Methicillin-Resistant Staphylococcus aureus Bacteremia , 2017, Antimicrobial Agents and Chemotherapy.

[2]  O. Slanař,et al.  Importance of vancomycin loading doses in intermittent infusion regimens. , 2017, Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy.

[3]  M. Rybak,et al.  Identification of Vancomycin Exposure-Toxicity Thresholds in Hospitalized Patients Receiving Intravenous Vancomycin , 2017, Antimicrobial Agents and Chemotherapy.

[4]  C. Giuliano,et al.  Effect of vancomycin initial dosing on time to systemic inflammatory response syndrome resolution in patients with methicillin-resistant Staphylococcus aureus bacteremia , 2017, Journal of chemotherapy.

[5]  Alexis Peralta,et al.  Pharmacokinetic Assessment of Vancomycin Loading Dose in Critically Ill Patients , 2017, Antimicrobial Agents and Chemotherapy.

[6]  V. Afreixo,et al.  Evaluation of vancomycin MIC creep in methicillin-resistant Staphylococcus aureus infections-a systematic review and meta-analysis. , 2017, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[7]  C. Thomson,et al.  Management of Adults with Hospital-acquired and Ventilator-associated Pneumonia. , 2016, Annals of the American Thoracic Society.

[8]  Peggy Cruse,et al.  Management of Adults With Hospital-acquired and Ventilator-associated Pneumonia: 2016 Clinical Practice Guidelines by the Infectious Diseases Society of America and the American Thoracic Society. , 2016, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[9]  D. Levine,et al.  Daptomycin Improves Outcomes Regardless of Vancomycin MIC in a Propensity-Matched Analysis of Methicillin-Resistant Staphylococcus aureus Bloodstream Infections , 2016, Antimicrobial Agents and Chemotherapy.

[10]  R. Arnold,et al.  High Single-dose Vancomycin Loading Is Not Associated With Increased Nephrotoxicity in Emergency Department Sepsis Patients. , 2016, Academic emergency medicine : official journal of the Society for Academic Emergency Medicine.

[11]  R. Kullar,et al.  Association between Vancomycin Day 1 Exposure Profile and Outcomes among Patients with Methicillin-Resistant Staphylococcus aureus Infective Endocarditis , 2015, Antimicrobial Agents and Chemotherapy.

[12]  F. Koura,et al.  Pharmacokinetics of Vancomycin in Extremely Obese Patients with Suspected or Confirmed Staphylococcus aureus Infections , 2015, Pharmacotherapy.

[13]  G. Drusano,et al.  Vancomycin exposure in patients with methicillin-resistant Staphylococcus aureus bloodstream infections: how much is enough? , 2014, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[14]  Roger W. Jelliffe,et al.  Are Vancomycin Trough Concentrations Adequate for Optimal Dosing? , 2013, Antimicrobial Agents and Chemotherapy.

[15]  Ronald N. Jones,et al.  Evaluation of Vancomycin Susceptibility Testing for Methicillin-Resistant Staphylococcus aureus: Comparison of Etest and Three Automated Testing Methods , 2013, Journal of Clinical Microbiology.

[16]  Anand Kumar,et al.  Vancomycin pharmacodynamics and survival in patients with methicillin-resistant Staphylococcus aureus-associated septic shock. , 2013, International Journal of Antimicrobial Agents.

[17]  D. Alexander,et al.  Performance of a vancomycin dosage regimen developed for obese patients. , 2012, American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists.

[18]  A. Padiglione,et al.  Simple approach to improving vancomycin dosing in intensive care: a standardised loading dose results in earlier therapeutic levels , 2012, Internal medicine journal.

[19]  M. Boro,et al.  Determining vancomycin clearance in an overweight and obese population. , 2011, American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists.

[20]  Sara E Cosgrove,et al.  Clinical practice guidelines by the infectious diseases society of america for the treatment of methicillin-resistant Staphylococcus aureus infections in adults and children: executive summary. , 2011, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[21]  G. Drusano,et al.  Larger Vancomycin Doses (at Least Four Grams per Day) Are Associated with an Increased Incidence of Nephrotoxicity , 2008, Antimicrobial Agents and Chemotherapy.

[22]  Á. Soriano,et al.  Influence of vancomycin minimum inhibitory concentration on the treatment of methicillin-resistant Staphylococcus aureus bacteremia. , 2008, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[23]  M. Rybak,et al.  Outcome Assessment of Minimizing Vancomycin Monitoring and Dosing Adjustments , 1999, Pharmacotherapy.

[24]  L. Bauer,et al.  Vancomycin dosing in morbidly obese patients , 1998, European Journal of Clinical Pharmacology.

[25]  R. Slaughter,et al.  Vancomycin Pharmacokinetics in a Patient Population: Effect of Age, Gender, and Body Weight , 1994, Therapeutic drug monitoring.

[26]  R. Blouin,et al.  Vancomycin pharmacokinetics in normal and morbidly obese subjects , 1982, Antimicrobial Agents and Chemotherapy.

[27]  M. Zervos,et al.  Comparative Effectiveness of Vancomycin Versus Daptomycin for MRSA Bacteremia With Vancomycin MIC >1 mg/L: A Multicenter Evaluation. , 2016, Clinical therapeutics.

[28]  Sara E Cosgrove,et al.  Clinical practice guidelines by the infectious diseases society of america for the treatment of methicillin-resistant Staphylococcus aureus infections in adults and children. , 2011, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[29]  D. Levine,et al.  Therapeutic monitoring of vancomycin in adult patients: a consensus review of the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, and the Society of Infectious Diseases Pharmacists. , 2009, American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists.